The Efficacy Evaluation of CHOLESWISE Pressed Candy on Cardiovascular Health

TCI

Status

Completed

Conditions

Cardiovascular Diseases

Treatments

Dietary Supplement: CHOLESWISE pressed candy

Dietary Supplement: Placebo pressed candy

Study type

Interventional

Funder types

Industry

Identifiers

2021-KY-24-01

Details and patient eligibility

About

To assess the efficacy evaluation of CHOLESWISE Pressed Candy on cardiovascular disease risk factors

Full description

This is a single center, randomized, double-blind and placebo controlled study. Subjects are informed to consume the samples every day for 8 weeks.

Enrollment

60 patients

Sex

All

Ages

30+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age ≥ 30 years old, no gender limit;
Patients with high blood pressure (systolic blood pressure> 120 mmHg or diastolic blood pressure> 80 mmHg) or high blood lipids (TC ≥ 5.18 mmol/L or TG ≥ 1.7 mmol/L), and no medication is used;
Fully understand the purpose, benefits, potential risks and side effects of this research, and can objectively cooperate with doctors to complete the examination and assessment of diseases and physical conditions;
People who voluntarily agree and sign an informed consent form.

Exclusion criteria

People with a history of dyspepsia would affect the absorption of the test product;
Any situation that may affect trial process, including difficult-to-control organic disease or infection, unstable angina pectoris, congestive heart failure and other severe disease;
People with symptomatic and difficult-to-control neurological, mental diseases or mental disorders;
Pregnant or breast-feeding women or women who have a positive result on a pregnancy test;
Allergic to the components of the test product;
Take supplementary foods and health supplements with the same efficacy two weeks before and during the test.